Catalyst Pharma's lead drug succeeds in late-stage study
September 29, 2014 at 16:05 PM EDT
Sept 29 (Reuters) - Catalyst Pharmaceutical Partners Inc said its lead drug was found superior in treating symptoms associated with a rare autoimmune disorder, compared with a placebo.
